Aspire Biopharma Holdings ASBP
NASDAQ ASBP
$8.35 +0.16 (+1.95%)
At close: Sep 30, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings (ASBP) Revenue (2025 - 2026)

Updated

Aspire Biopharma Holdings' Revenue was $63,104 in Q2 2026, up 122.6% from the prior quarter.

Analysis

Aspire Biopharma Holdings (ASBP) Revenue (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aspire Biopharma Holdings' Revenue was $97,659 through Jun 30, 2026; for FY2025, it was $6,202.

  • Per Business Quant data, ASBP's Revenue in the three quarters before Q2 2026 was $28,353 (Q1 2026), $4,261 (Q4 2025) and $1,941 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Aspire Biopharma Holdings 61.43 Mn 40.45 Mn -30,086.00 63,104.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63,104.00
Mar 31, 2026 28,353.00
Dec 31, 2025 4,261.00
Sep 30, 2025 1,941.00
API Access

Aspire Biopharma Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ASBP&period=max&api_key=YOUR_API_KEY